Homomultimeric FAP Inhibitor-Based Radioligands for Cancer Theranostics: Design Principles, Structure–Function Relationships, and Preclinical Performance

Fibroblast activation protein (FAP) has emerged as a promising target for the development of cancer radiotheranostics due to its selective overexpression in cancer-associated fibroblasts (CAFs) within the tumor stroma. Affinity and selectivity refer to the binding affinities of FAP inhibitors toward...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Zhiyang Wu, Eleni Gourni, Sanjana Ballal, Pieter Van der Veken, Frank Roesch
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	MDPI AG 2026-06-01
Edice:	Molecules
Témata:	homomultimeric FAPI ligands theranostics fibroblast activation protein (FAP) radioligand therapy (RLT) dimerization
On-line přístup:	https://www.mdpi.com/1420-3049/31/12/2124
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!